Anticoagulant drugs Flashcards
Virchow’s triad
Hypercoagulability, endothelial injury and blood stasis
Process of haemostasis
Formation of platelet plug (adhesion, aggregation, activation)
Propagation of clotting (pathways activated, clotting cascade, recruiting platelets)
Termination of clotting (limiting clot formation and stopping the cascade)
Fibrinolysis (activating plasmin and lysis of fibrin)
Antiplatelet examples
- Aspirin
- Clopidogrel
- Dipyridamole
- Arterial
Anticoagulants
- Warfarin
- Heparins
- Apixaban
- Rivaroxaban
- Dabigatran
- Arterial and venous
- DOAC - direct oral anticoagulant drug- replacing warfarin
Thrombolytics
TPA
Arterial and venous
Anticoagulants
- Treatment of thromboembolism: arterial (warfarin and DOACs) and venous: heparins, DOACs and warfarins
- Prevention of thromboembolism: prevention of stroke with AF (warfarin and DOACs), mechanical heart valves (warfarin), VTE prophylaxis, high risk thrombophilias
What is the CHADVASc score
Measures stroke risk in patients with AF
0 = no anticoagulation needed
1 = probably needed
>1 = definitely immediately needed
HASBLED score
Bleeding risk for patients on anti-coagulation
WELLs score
Assesses the risk of a patient getting a DVT or PE
DOAC examples
Apixaban, rivaroxiban and dabigatran
How do DOACs work?
- Rivaroxiban and apixiban bind to 10a inhibit activation of thrombin from prothrombin
- Dabigatran binds directly to prothrombin to stop coagulation cascade
Side effects of dabigatran
Dyspepsia and GI
DOAC reversal
Idarucizumab for dabigatran
Heparins
Binds to antithrombin to increase thrombin inhibition
Side effects of heparins
bleeding, thrombocytopenia, hypokalaemia, osteoporosis, renal failure = accumulation